The report provides a detailed analysis of drivers & opportunities, top investment pockets, market size & estimations, and competitive scenario. The global anesthesia and respiratory devices market size is expected to garner $40.35 billion by 2026, from $25.54 billion in 2018, growing at a CAGR of 9.8% from 2019 to 2026.
Rise in prevalence of respiratory diseases, increase in number of surgical procedures, surge in pollution level, and increase in tobacco consumption drive the growth in the market. In addition, rapid urbanization and supportive government policies supplement the market growth. However, risks related to therapeutic and diagnostic devices for neonates and low adoption rate of new technologies restrain the growth of the market. On the other hand, increase in demand for therapeutic devices for homecare settings and surge in healthcare expenditures create new opportunities in the industry.
The report analyzes and forecasts the anesthesia and respiratory devices market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global anesthesia and respiratory devices market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the anesthesia and respiratory devices market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of anesthesia and respiratory devices market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Competitive Landscape is the most valuable part of this report
Leading market players analyzed in the report include Teleflex Incorporated, Smiths Group Plc., SunMed, Medtronic Plc., ResMed Inc., Koninklijke Philips N.V., Masimo Corporation, Hamilton Medical AG, Invacare Corporation, GE Healthcare, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, and others.
Key financial developments of a particular company and product & company overview are some of the elements that help in acquiring information about top vendors in the market. This particular section has also included a SWOT analysis of the companies featured in the report. This will help the audience in knowing about opportunities, strengths, threats and weaknesses that are facing by the key vendors in the chemical and material industry across the world. As the competitive landscape is the most valuable part of any report, it consists of all the required information for the detailed study of top players functioning in the industries. It is also an interesting part to find how exactly these key manufacturers implement various strategies to secure the top rank in the industry. Such an in-depth information is useful for the new entrants into the industry as they would be able to learn a bit from these key vendors. Similarly, the information provided in the research report will also be valuable for the renowned key players as well, as they come to know the strategies of their counterparts to sustain in the competitive industry.
Segmentation
By Product Type
By End User
By Region
Top of Form
Report coverage
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Section 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Section 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Section 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Winning Strategies
3.2.2. Top Investment Pockets
3.3. Top Player Positioning, 2016
3.4. Porter’s Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Growth in elderly population throughout the world
3.5.1.2. Rise in prevalence of respiratory diseases
3.5.1.3. Increase in cases of preterm birth
3.5.1.4. Technological advancement in anesthesia monitoring
3.5.1.5. Increase in number of surgeries
3.5.2. Restrains
3.5.2.1. High equipment cost
3.5.2.2. Regulatory compliances
3.5.2.3. Lack of awareness in developing region
3.5.2.4. Harmful effects of respiratory devices on neonates
3.5.3. Opportunities
3.5.3.1. Increased demand for quality healthcare monitoring
3.5.3.2. Increase in awareness and improvement in the healthcare infrastructure in emerging nations create huge opportunities for manufacturers
3.5.3.3. Rise in the demand for home care respiratory devices
Section 4: ANESTHESIA AND RESPIRATORY DEVICES MARKET BY PRODUCT
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Anesthesia Devices
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Anesthesia Delivery Machines
4.2.4.1. Market size & forecast
4.2.5. Anesthesia Disposables and Accessories
4.2.5.1. Market size & forecast
4.2.5.1.1. Anesthesia Circuits
4.2.5.1.1.1. Market size and forecast
4.2.5.1.2. Anesthesia Masks
4.2.5.1.2.1. Market size and forecast
4.2.5.1.3. Resuscitators
4.2.5.1.3.1. Market size and forecast
4.2.5.1.4. Laryngoscopes
4.2.5.1.4.1. Market size and forecast
4.2.5.1.5. Flexible Intubation Scopes
4.2.5.1.5.1. Market size and forecast
4.2.5.1.6. Supraglottic Airways
4.2.5.1.6.1. Market size and forecast
4.2.5.1.7. Ventilator Circuits
4.2.5.1.7.1. Market size and forecast
4.2.5.1.8. Heat and moisture exchangers (HME's)
4.2.5.1.8.1. Market size and forecast
4.2.5.1.9. Regional Anesthesia and Pain Devices
4.2.5.1.9.1. Market size and forecast
4.2.5.1.10. Others
4.2.5.1.10.1. Market size and forecast
4.2.6. Anesthesia Monitors
4.2.6.1. Market size & forecast
4.2.6.1.1. Basic Anesthesia Monitors
4.2.6.1.1.1. Market size and forecast
4.2.6.1.2. Advanced Anesthesia Monitors
4.2.6.1.2.1. Market size and forecast
4.2.6.1.3. Integrated Anesthesia Workstations
4.2.6.1.3.1. Market size and forecast
4.2.7. Anesthesia Information Management Systems (AIMS)
4.2.7.1. Market size & forecast
4.3. RESPIRATORY DEVICE
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Therapeutic Devices
4.3.4.1. Market size and forecast
4.3.4.2. Positive Airway Pressure (PAP) Devices
4.3.4.2.1. Market size and forecast
4.3.4.2.2. Continuous Positive Airway Pressure (CPAP) Devices
4.3.4.2.2.1. Market size and forecast
4.3.4.2.3. Bilevel PAP (BPAP) Devices
4.3.4.2.3.1. Market size and forecast
4.3.4.2.4. Automatic Positive Airway Pressure (APAP) Devices
4.3.4.2.4.1. Market size and forecast
4.3.4.3. Masks
4.3.4.3.1. Market size and forecast
4.3.4.3.2. Nasal Masks
4.3.4.3.2.1. Market size and forecast
4.3.4.3.3. Full-face Masks
4.3.4.3.3.1. Market size and forecast
4.3.4.3.4. Nasal pillow Masks
4.3.4.3.4.1. Market size and forecast
4.3.4.3.5. Oral Masks
4.3.4.3.5.1. Market size and forecast
4.3.4.4. Ventilators
4.3.4.4.1. Market size and forecast
4.3.4.4.2. Adult Ventilators
4.3.4.4.2.1. Market size and forecast
4.3.4.4.3. Infant/neonatal Ventilators
4.3.4.4.3.1. Market size and forecast
4.3.4.5. Nebulizers
4.3.4.5.1. Market size and forecast
4.3.4.6. Humidifiers
4.3.4.6.1. Market size and forecast
4.3.4.7. Oxygen concentrators
4.3.4.7.1. Market size and forecast
4.3.4.7.2. Fixed Oxygen Concentrators
4.3.4.7.2.1. Market size and forecast
4.3.4.7.2.2. Portable Oxygen Concentrators
4.3.4.7.2.3. Market size and forecast
4.3.4.8. Inhalers
4.3.4.8.1. Market size and forecast
4.3.4.8.2. Dry Powder Inhalers (DPIs)
4.3.4.8.2.1. Market size and forecast
4.3.4.8.3. Metered Dose Inhalers (MDIs)
4.3.4.8.3.1. Market size and forecast
4.3.4.8.4. Soft Mist Inhalers (SMIs)
4.3.4.8.4.1. Market size and forecast
4.3.4.9. Reusable Resuscitators
4.3.4.9.1. Market size and forecast
4.3.4.9.2. Adult Resuscitators
4.3.4.9.2.1. Market size and forecast
4.3.4.9.3. Infant/neonatal Resuscitators
4.3.4.9.3.1. Market size and forecast
4.3.4.10. Nitric Oxide Delivery Units
4.3.4.10.1. Market size and forecast
4.3.4.11. Capnographs
4.3.4.11.1. Market size and forecast
4.3.4.12. Gas Analyzers
4.3.4.12.1. Market size and forecast
4.3.4.13. Oxygen Hoods
4.3.4.13.1. Market size and forecast
4.3.5. Monitoring Devices
4.3.5.1. Pulse Oximeters
4.3.5.1.1. Market size and forecast
4.3.5.1.2. Pediatric Pulse Oximeters
4.3.5.1.2.1. Market size and forecast
4.3.5.1.3. Wrist-worn Pulse Oximeters
4.3.5.1.3.1. Market size and forecast
4.3.5.1.4. Hand-held Pulse Oximeters
4.3.5.1.4.1. Market size and forecast
4.3.5.1.5. Fingertip Pulse Oximeters
4.3.5.1.5.1. Market size and forecast
4.3.5.1.6. Table-top/bedside Pulse Oximeters
4.3.5.1.6.1. Market size and forecast
4.3.6. Diagnostic Devices
4.3.6.1. Market size and forecast
4.3.6.2. Spirometers
4.3.6.2.1. Market size and forecast
4.3.6.3. Polysomnography (PSG) Devices
4.3.6.3.1. Market size and forecast
4.3.6.3.2. Peak Flow Meters
4.3.6.3.2.1. Market size and forecast
4.3.7. Consumables and Accessories
4.3.7.1. Market size and forecast
4.3.7.2. Disposable Masks
4.3.7.2.1. Market size and forecast
4.3.7.3. Disposable Resuscitators
4.3.7.3.1. Market size and forecast
4.3.7.4. Tracheostomy Tubes
4.3.7.4.1. Market size and forecast
4.3.7.5. Nasal Cannulas
4.3.7.5.1. Market size and forecast
4.3.7.6. Others
4.3.7.6.1. Market size and forecast
Section 5: ANESTHESIA AND RESPIRATORY DEVICES MARKET BY END USERS
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Hospitals
5.2.1. Market size & forecast
5.3. Ambulatory service centers (ASC)
5.3.1. Market size & forecast
5.4. Homecare
5.4.1. Market size and forecast
5.5. Clinics
5.5.1. Market size & forecast
Section 6: ANESTHESIA AND RESPIRATORY DEVICES MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Key market trends
6.2.3. Growth factors and opportunities
6.2.4. North America Market size and forecast
6.2.5. U.S. Market size and forecast
6.2.6. Canada Market size and forecast
6.2.7. Mexico Market size and forecast
6.3. Europe
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Europe market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. UK market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Spain market size and forecast
6.3.9. Rest of Europe market size and forecast
6.4. Asia-Pacific
6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Asia-Pacific market size and forecast
6.4.4. Japan Market size and forecast
6.4.5. China Market size and forecast
6.4.6. Australia Market size and forecast
6.4.7. India Market size and forecast
6.4.8. South Korea Market size and forecast
6.4.9. Rest of the Asia-Pacific Market size and forecast
6.5. LAMEA
6.5.1. Key Market Trends
6.5.2. Key growth factors and opportunities
6.5.3. LAMEA market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast
Section 7: COMPANY PROFILES
7.1. 3M Company
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Ambu S/A
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. Becton, Dickinson and Company
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Chart Industries Inc.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. Drägerwerk AG & Co. KGaA
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. Fisher & Paykel Healthcare Limited
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. GE Healthcare (A healthcare division Of GE Company)
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Hamilton Medical AG
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Product portfolio
7.9. Invacare Corporation
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Koninklijke Philips N.V.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
7.11. Masimo Corporation
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Product portfolio
7.11.4. Business performance
7.12. Medtronic Plc.
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Product portfolio
7.12.5. Business performance
7.13. ResMed Inc.
7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Product portfolio
7.13.4. Business performance
7.13.5. Key strategic moves and developments
7.14. Smiths Group Plc.
7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Product portfolio
7.14.5. Business performance
7.15. SunMed
7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Product portfolio
7.16. Teleflex Incorporated
7.16.1. Company overview
7.16.2. Company snapshot
7.16.3. Operating business segments
7.16.4. Product portfolio
7.16.5. Business performance
7.16.6. Key strategic moves and developments
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers